News
A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...
Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
Fiona Havers, who oversees CDC respiratory virus data, told colleagues she no longer had confidence the data would be used ...
A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated ...
The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.
Explore more
Tourists in Israel and Lebanon have found themselves stranded at airports amid Israel's conflict with Iran. Fiona Jones ...
A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from infectious diseases like COVID-19 has resigned in protest following Health and ...
The 17 members of the CDC's vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left ...
The Federal Reserve meets today with potential impacts on your finances, plus a warning for anyone reusing passwords.
Covid-19 and RSV head data scientist dramatically quits saying she doesn’t trust RFK Jr department to use it ‘objectively’ - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results